Search clinical trials for: Alpha Particle

Total 9603 results

Perspective Therapeutics

Recruiting

MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma

Metastatic Melanoma | Melanoma Stage IV | Melanoma Stage III | Recurrent Melanoma (Skin)

United States
Perspective Therapeutics

Recruiting

Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors ([212-Pb]-VMT)

Meningioma | Pheochromocytoma | Paraganglioma | Gastroenteropancreatic Neuroendocrine Tumor | Neuroendocrine Tumors Unresectable | Neuroendocrine Tumor Metastatic | Bronchial Neuroendocrine Tumor

United States
Modulation Therapeutics, Inc.
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

Targeted Alpha Particle Radiotherapy for Metastatic Uveal Melanoma

Uveal Melanoma | Metastatic

United States
Bayer
Merck Sharp & Dohme LLC

Terminated

Study to Test the Safety and How Radium-223 Dichloride an Alpha Particle-emitting Radioactive Agent Works in Combination With Pembrolizumab an Immune Checkpoint Inhibitor in Patients With Stage IV Non-small Cell Lung Cancer With Bone Metastases

Carcinoma, Non-Small-Cell Lung

Spain, Belgium, Netherlands, United States
Bayer

Completed

Study to Gather Information on the Safety and How Radium-223 Dichloride, an Alpha Particle-emitting Radioactive Agent, Works Under Routine Clinical Practice in Taiwan in Patients With Castration-resistant Prostate Cancer (CRPC) Which Has Spread to the Bone (RAPIT)

Castration-resistant Prostate Cancer

Taiwan

This is a preview

Log in or create a free account to see all matching trials and use the full search.

Log in Register

Subscribe